BOLT vs. LAZR

Last updated Jul 17, 2026

BOLT (Bolt Biotherapeutics, Inc.) and LAZR (Luminar Technologies, Inc.) are both stocks. BOLT operates in Biotechnology (Healthcare), while LAZR operates in Software - Application (Technology). At a correlation of -0.33, they often move in opposite directions.

Performance

BOLT vs. LAZR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bolt Biotherapeutics, Inc. (BOLT) and Luminar Technologies, Inc. (LAZR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BOLT

• 1D: -0.48%
• 1M: -2.78%
• 6M: -39.97%
• YTD: -23.37%
• 1Y: -27.00%
• 3Y*: -46.26%
• 5Y*: -56.41%
• 10Y*: —

LAZR

• 1D: -6.22%
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BOLT vs. LAZR - Yearly Performance Comparison

	2026 (YTD)
BOLT Bolt Biotherapeutics, Inc.	7.30%
LAZR Luminar Technologies, Inc.	-22.50%

Correlation

The correlation between BOLT and LAZR is -0.33, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 30, 2026	-0.33

Fundamentals

Market Cap BOLT : $8.05M LAZR : $775.60K
EPS BOLT : -$4.31 LAZR : -$3.37
PS Ratio BOLT : 4.43 LAZR : 35.47
Total Revenue (TTM) BOLT : $6.50M LAZR : $75.75M
Gross Profit (TTM) BOLT : $4.98M LAZR : -$16.13M
EBITDA (TTM) BOLT : -$28.67M LAZR : -$161.26M

Return for Risk

BOLT vs. LAZR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOLT

BOLT Risk / Return Rank: 27
BOLT Sharpe Ratio Rank: 28
BOLT Sortino Ratio Rank: 30
BOLT Omega Ratio Rank: 30
BOLT Calmar Ratio Rank: 23
BOLT Martin Ratio Rank: 23

LAZR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOLT vs. LAZR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bolt Biotherapeutics, Inc. (BOLT) and Luminar Technologies, Inc. (LAZR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BOLT	LAZR	Difference
Sharpe ratio: Return per unit of total volatility	-0.37	—	—
Sortino ratio: Return per unit of downside risk	-0.12	—	—
Omega ratio: Gain probability vs. loss probability	0.99	—	—
Calmar ratio: Return relative to maximum drawdown	-0.58	—	—
Martin ratio: Return relative to average drawdown	-0.98	—	—

Drawdowns

BOLT vs. LAZR - Drawdown Comparison

The maximum BOLT drawdown since its inception was -99.53%, which is greater than LAZR's maximum drawdown of -23.36%. Use the drawdown chart below to compare losses from any high point for BOLT and LAZR.

Drawdown Indicators

	BOLT	LAZR	Difference
Max Drawdown Largest peak-to-trough decline	-99.53%	-23.36%	-76.17%
Max Drawdown (1Y) Largest decline over 1 year	-46.69%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-87.40%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-98.98%	—	—
Current Drawdown Current decline from peak	-99.48%	-23.36%	-76.12%
Average Drawdown Average peak-to-trough decline	-90.18%	-15.14%	-75.04%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.59%	—	—

Volatility

Volatility by Period

	BOLT	LAZR	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.91%	—	—
Volatility (6M) Calculated over the trailing 6-month period	55.63%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	72.76%	81.36%	-8.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	74.31%	81.36%	-7.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	75.79%	81.36%	-5.57%

Dividends

BOLT vs. LAZR - Dividend Comparison

Neither BOLT nor LAZR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both BOLT and LAZR in my portfolio?

BOLT and LAZR have a correlation of -0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.